Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. (Q38362260)

2 September 2017

Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. (English)

1 reference

2 September 2017

Artur Schmidtchen

1

1 reference

2 September 2017

Inga-Maria Frick

2

1 reference

2 September 2017

Emma Andersson

3

1 reference

2 September 2017

Hans Tapper

4

1 reference

2 September 2017

Lars Björck

5

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

2 September 2017

Molecular Microbiology

1 reference

2 September 2017

46

1 reference

2 September 2017

1

1 reference

2 September 2017

157-168

1 reference

The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface

2 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Innate immunity and the normal microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Biochemical and antibacterial analysis of human wound and blister fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Structural gene and complete amino acid sequence of Pseudomonas aeruginosa IFO 3455 elastase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

The role of antimicrobial peptides in animal defenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Streptococcal cysteine proteinase releases kinins: a virulence mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Isolation and structural determination of novel sulfated hexasaccharides from squid cartilage chondroitin sulfate E that exhibits neuroregulatory activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Antimicrobial peptides in mammalian and insect host defence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Bacterial phosphorylcholine decreases susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Innate antimicrobial peptide protects the skin from invasive bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Differential proteinase expression by Pseudomonas aeruginosa derived from chronic leg ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

21 January 2018

Human beta-defensin-2

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Defensins in granules of phagocytic and non-phagocytic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Sequence and specificity of two antibacterial proteins involved in insect immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Are bacterial proteinases pathogenic factors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Substrate specificity in the highly heterogeneous M4 peptidase family is determined by a small subset of amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2958.2002.03146.X

10.1046/J.1365-2958.2002.03146.X

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference